J7192 Factor viii recombinant not otherwise specified
Also known as: recombinant Factor VIII, rFVIII, Factor VIII concentrate
Injection of Factor VIII recombinant, not otherwise specified, for treatment of hemophilia A and Factor VIII deficiency.
In Plain Language
clotting factor replacement; hemophilia A treatment
Clinical Context
Used for routine prophylaxis and on-demand treatment of bleeding episodes in hemophilia A patients.
RVU Information
CPT J7192 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J7192?
CPT J7192 (Factor viii recombinant not otherwise specified) is a J Codes (Drugs) code. Injection of Factor VIII recombinant, not otherwise specified, for treatment of hemophilia A and Factor VIII deficiency.
How is J7192 administered?
CPT J7192 is administered by a healthcare provider, typically via injection or infusion. Used for routine prophylaxis and on-demand treatment of bleeding episodes in hemophilia A patients. It is used by Hematology, Hemophilia Specialty Clinic, Pediatrics.
When is CPT J7192 used?
Used for routine prophylaxis and on-demand treatment of bleeding episodes in hemophilia A patients.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.